Blockade of CD40-CD154 interferes with human T cell engraftment in scid mice
Graduate School of Biomedical Sciences; Department of Medicine, Division of Diabetes
Life Sciences | Medicine and Health Sciences
Antibodies to the ligand for CD40 (CD154) have been shown to exert profound effects on the development of cell-mediated immune responses in mice. The present study shows that an antibody to human CD154 (hCD40L) inhibits in vivo Tetanus toxoid (TT) specific secondary antibody responses in hu-PBL-scid mice, as well as the expansion of xenoreactive human T cells in the scid mice. A possible cause for the reduced expansion of xenoreactive, human T cells, was the decreased expression of murine B7.1 and B7.2 caused by the administration of anti-hCD40L. Therefore, it may be that defective maturation of murine antigen-presenting cells impeded the priming and expansion of human xenoreactive T cells.
DOI of Published Version
Cell Transplant. 1998 Jan-Feb;7(1):25-35.
Foy TM, McIlraith M, Masters SR, Dunn JJ, Rossini AA, Shultz LD, Hesselton RM, Wagar EJ, Lipsky PE, Noelle RJ, Greiner DL. (1998). Blockade of CD40-CD154 interferes with human T cell engraftment in scid mice. GSBS Student Publications. https://doi.org/10.1016/S0963-6897(97)00113-9. Retrieved from https://escholarship.umassmed.edu/gsbs_sp/306